Tabula Rasa HealthCare, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
Amortization of deferred financing costs and debt discount
Deferred taxes
Stock-based compensation
Change in fair value of acquisition-related contingent consideration
Change in fair value of contingent consideration receivable
Acquisition-related contingent consideration paid
Intangible asset impairment
Impairment charges
Loss on divestiture of business
Other noncash items
Changes in operating assets and liabilities, net of effect of divestiture and acquisitions:
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Client claims receivables
Other assets
Accounts payable
Accrued expenses and other liabilities
Client claims payables
Other long-term liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of property and equipment
Software development costs
Purchases of intangible assets
Issuance of note receivable
Proceeds from repayment of note receivable
Acquisitions of businesses, net of cash acquired
Proceeds from divestiture of business
Net cash provided by (used in) investing activities

Cash flows from financing activities:
Payments for repurchase of common stock
Proceeds from exercise of stock options
Proceeds from disgorgement of short swing profits
Payments for employee taxes for shares withheld
Payments for debt financing costs
Borrowings on line of credit
Repayments of line of credit
Payments of equity offering costs
Repayments of long-term debt
Payment of acquisition-related notes payable
Payments of acquisition-related contingent consideration
Repayments of long-term debt and finance leases
Proceeds from issuance of convertible senior subordinated notes
Proceeds from sale of warrants
Purchase of convertible note hedges
Net cash (used in) provided by financing activities

Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash, beginning of period
Cash, cash equivalents and restricted cash, end of period
Supplemental disclosure of cash flow information:
Acquisition of equipment under capital leases
Purchases of property and equipment and software development included in accounts payable and accrued expenses
Purchases of property and equipment and software development through vendor financing arrangements
Cash paid for interest
Employee payroll taxes on exercise of stock options included in accrued expenses
Cash paid for taxes (income tax refund)
Interest costs capitalized to software development costs
Stock issued in connection with settlement of acquisition-related contingent consideration
Stock issued in connection with acquisitions
Fair value of promissory notes entered into in connection with acquisition

Comments